Ranolazine 70771-1500
Product NDC
70771-1500- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 10, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA210188
Need to source Ranolazine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranolazine | 1000 mg/1 |
Drug Class
Anti-anginal [EPC]Anti-anginal [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(4)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-1)
10 BLISTER PACK in 1 CARTON (70771-1500-4) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1500-2)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-5)
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-6)